Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Hein

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Archives of Toxicology|May 4, 2023
Effect of N-acetyltransferase 2 genetic polymorphism on 4,4'-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stressMariam R Habil, Raúl A Salazar-González, Mark A Doll, et al.
Pharmacogenetics and Genomics|February 1, 2007
Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2Yu Zang, Shuang Zhao, Mark A Doll, et al.
Molecular Carcinogenesis|August 13, 2011
NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenylLori M Millner, Mark A Doll, Jian Cai, et al.
Archives of Toxicology|July 12, 2019
Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4'-methylenedianilineRaúl A Salazar-González, Xiaoyan Zhang, Mark A Doll, et al.
Pharmacogenetics|July 1, 2004
Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1)Anwar Husain, David F Barker, J Christopher States, et al.
Biochemistry and Biophysics Reports|August 27, 2015
Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-AcetyltransferasesMarcus W Stepp, Galina Mamaliga, Mark A Doll, et al.
Environmental Toxicology and Pharmacology|April 17, 2025
Metabolism and genotoxicity of 4,4'-oxydianiline is dependent on N-acetyltransferase 2 genetic polymorphismRaul A Salazar-González, James T F Wise, Mark A Doll, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 21, 2009
N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white womenKathy B Baumgartner, Thomas J Schlierf, Dongyan Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 20, 2011
Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependentLori M Millner, Mark A Doll, Jian Cai, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 27, 2007
Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine systemLarissa Wakefield, Valerie Cornish, Hilary Long, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Archives of Toxicology|May 4, 2023
Effect of N-acetyltransferase 2 genetic polymorphism on 4,4'-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stressMariam R Habil, Raúl A Salazar-González, Mark A Doll, et al.
Pharmacogenetics and Genomics|February 1, 2007
Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2Yu Zang, Shuang Zhao, Mark A Doll, et al.
Molecular Carcinogenesis|August 13, 2011
NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenylLori M Millner, Mark A Doll, Jian Cai, et al.
Archives of Toxicology|July 12, 2019
Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4'-methylenedianilineRaúl A Salazar-González, Xiaoyan Zhang, Mark A Doll, et al.
Pharmacogenetics|July 1, 2004
Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1)Anwar Husain, David F Barker, J Christopher States, et al.
Biochemistry and Biophysics Reports|August 27, 2015
Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-AcetyltransferasesMarcus W Stepp, Galina Mamaliga, Mark A Doll, et al.
Environmental Toxicology and Pharmacology|April 17, 2025
Metabolism and genotoxicity of 4,4'-oxydianiline is dependent on N-acetyltransferase 2 genetic polymorphismRaul A Salazar-González, James T F Wise, Mark A Doll, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 21, 2009
N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white womenKathy B Baumgartner, Thomas J Schlierf, Dongyan Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 20, 2011
Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependentLori M Millner, Mark A Doll, Jian Cai, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 27, 2007
Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine systemLarissa Wakefield, Valerie Cornish, Hilary Long, et al.
Pageof 18